IPA's 9th Global Summit To Define The Future Of Pharmaceutical Quality

On June 27 and 28, the IPA or Indian Pharmaceutical Alliance, will hold the ninth Global Pharmaceutical Quality Summit in Mumbai. This year's summit focuses on 'Advances in Manufacturing and Quality – Patient Centricity.' The event will feature sessions on utilizing technology to shape the future of pharmaceutical operations and manufacturing over the next decade.

The summit will feature speakers from major global regulatory bodies like WHO, USAFDA, DCHI and MHRA, as well as industry leaders, academics, and experts. They will be discussing the prominent issues in quality management and provide updates on regulations. With a set of impressive & knowledgeable speakers and panelists, the summit guarantees valuable insights into the changing dynamics of pharmaceutical manufacturing. Nilesh Gupta, Chair of the Quality Forum at IPA and Managing Director of Lupin, will inaugurate the summit, which will be attended by stakeholders from the industry, government, and global experts. Following this, a report titled ‘Shaping the Next Decade of Indian Pharmaceutical Manufacturing’ will be released. The Summit will address a variety of strategic subjects, considering current and future trends in Quality and Manufacturing. This will include topics like the future of AI applications in pharmaceutical quality & operations, smart operations, pharmaceutical operations, biopharma opportunities and cyber security..

Participants will have the opportunity to gain deeper insights into recent focus areas such as significance of Data and Documentation, Talent Capable Building and Quality Management Maturity Models. Additionally, guidance documents on Good Engineering Practices and Process Analytical Technology (PAT) for Oral Solids and APIs will be introduced at the Summit. Sudarshan Jain, Secretary General, the Indian Pharmaceutical Alliance said in a statement, “The Indian pharmaceutical industry is undergoing a transformative era marked by advancements in manufacturing such as continuous manufacturing, green chemistry, and 3D printing. These initiatives must prioritise patient-centricity. 

He further added, “By focusing on patient needs in design and manufacturing, India will further cement its position as ‘The Pharmacy of the World’. Quality is a fundamental tenet of the pharmaceutical sector. IPA is committed to making India the global quality benchmark. The 9th GPQS summit is a step to bring domain experts, global regulators, and industry to one platform to drive discussions on key priorities to define the next decade for pharmaceutical operations and manufacturing.”

McKinsey & Company is the knowledge partner for the summit. The major highlight of the event is the panel discussion that will feature top executives from major pharmaceutical companies, focused on shaping the future of pharmaceutical operations and manufacturing over the next decade.